99.91
Rhythm Pharmaceuticals Inc Azioni (RYTM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
48.31%
48.50
|
32.70 | 41.83 | 33.25 | 29.08 |
Cost Of Revenue |
51.95%
5.543
|
3.648 | 3.787 | 3.828 | 2.947 |
Gross Profit |
47.85%
42.96
|
29.06 | 38.04 | 29.42 | 26.13 |
|
16.03%
88.25
|
76.06 | 79.30 | 73.31 | 66.61 |
Benefits Costs and Expenses |
15.43%
94.80
|
82.12 | 85.21 | 77.24 | 60.86 |
Costs And Expenses |
17.68%
93.80
|
79.71 | 83.08 | 77.14 | 69.56 |
Operating Income/Loss |
3.63%
-45.30
|
-47.00 | -41.26 | -43.88 | -40.48 |
Nonoperating Income/Loss |
58.62%
-0.999
|
-2.414 | -2.127 | -0.10 | 8.696 |
Income/Loss From Continuing Operations Before Tax |
6.32%
-46.30
|
-49.42 | -43.38 | -43.98 | -31.78 |
Income Tax Expense/Benefit |
321.25%
0.337
|
0.08 | -0.09 | -0.344 | 0.479 |
Income/Loss From Continuing Operations After Tax |
5.79%
-46.63
|
-49.50 | -43.29 | -43.64 | -32.26 |
|
5.79%
-46.63
|
-49.50 | -43.29 | -43.64 | -32.26 |
Preferred Stock Dividends And Other Adjustments |
1.349
|
- | 1.339 | 1.329 | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.99%
63.68
|
63.06 | 0.2019 | 61.22 | 61.01 |
Diluted Average Shares |
0.99%
63.68
|
63.06 | 0.2019 | 61.22 | 61.01 |
Basic Earnings Per Share |
7.41%
-0.75
|
-0.81 | -0.72 | -0.73 | -0.55 |
Diluted Earnings Per Share |
7.41%
-0.75
|
-0.81 | -0.72 | -0.73 | -0.55 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
1.349
|
- | 1.339 | 1.329 | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):